Novartis chases rivals with next wave of cancer immunotherapy – Reuters
Reuters |
Novartis chases rivals with next wave of cancer immunotherapy
Reuters S), lagging some other big drugmakers in the first wave of immunotherapy drugs that are revolutionizing cancer treatment, hopes to catch up by focusing on the next wave of immune system-boosting medicines. Setting out its research objectives in slides … |
